Latest Trials
| EudraCT Number: 2004-001823-39 | Sponsor Protocol Number: 103502 | Start Date: 2004-11-15 | ||||||
| Sponsor Name: GlaxoSmithKline Biologicals | ||||||||
| Full Title: An open, randomized, controlled, phase II study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ 11-valent pneumococcal conjugate vaccine, when administered intramuscularly... | ||||||||
| Medical condition: Prophylactic vaccination against pneumococcal diseases in infants and diseases caused by Neisseria meningitidis C. | ||||||||
|
||||||||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |||||||
| Trial protocol: SE (Completed) | ||||||||
| Trial results: View results | ||||||||